These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32899022)

  • 1. Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial.
    Haroon SW; Tai BC; Ling LH; Teo L; Davenport A; Schurgers L; Teo BW; Khatri P; Ong CC; Low S; Yeo XE; Tan JN; Subramanian S; Chua HR; Tan SY; Wong WK; Lau TW
    Medicine (Baltimore); 2020 Sep; 99(36):e21906. PubMed ID: 32899022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.
    Krueger T; Schlieper G; Schurgers L; Cornelis T; Cozzolino M; Jacobi J; Jadoul M; Ketteler M; Rump LC; Stenvinkel P; Westenfeld R; Wiecek A; Reinartz S; Hilgers RD; Floege J
    Nephrol Dial Transplant; 2014 Sep; 29(9):1633-8. PubMed ID: 24285427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
    Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
    Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.
    Holden RM; Booth SL; Zimmerman D; Moist L; Norman PA; Day AG; Menard A; Fu X; Shea MK; Babiolakis CS; Nolan R; Turner ME; Ward E; Kaufmann M; Adams MA; Heyland DK
    Nephrol Dial Transplant; 2023 Feb; 38(3):746-756. PubMed ID: 35641194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study.
    De Vriese AS; Caluwé R; Pyfferoen L; De Bacquer D; De Boeck K; Delanote J; De Surgeloose D; Van Hoenacker P; Van Vlem B; Verbeke F
    J Am Soc Nephrol; 2020 Jan; 31(1):186-196. PubMed ID: 31704740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK).
    Haroon S; Davenport A; Ling LH; Tai BC; Teo LL; Schurgers L; Chen Z; Shroff R; Fischer DC; Khatri P; Low S; Tan JN; Chua HR; Teo BW; Ong CC; Subramanian S; Yeo XE; Wong WK; Lau TW
    Kidney Int Rep; 2023 Sep; 8(9):1741-1751. PubMed ID: 37705910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.
    Roumeliotis S; Roumeliotis A; Georgianos PI; Thodis E; Schurgers LJ; Maresz K; Eleftheriadis T; Dounousi E; Tripepi G; Mallamaci F; Liakopoulos V
    PLoS One; 2022; 17(8):e0273102. PubMed ID: 35976944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials.
    Caluwé R; Pyfferoen L; De Boeck K; De Vriese AS
    Clin Kidney J; 2016 Apr; 9(2):273-9. PubMed ID: 26985380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Naito T; Tanji C; Usui K; Doi S; Masaki T; Shigemoto K
    Ren Fail; 2019 Nov; 41(1):770-777. PubMed ID: 31538831
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.
    Holden RM; Booth SL; Day AG; Clase CM; Zimmerman D; Moist L; Shea MK; McCabe KM; Jamal SA; Tobe S; Weinstein J; Madhumathi R; Adams MA; Heyland DK
    Can J Kidney Health Dis; 2015; 2():17. PubMed ID: 26075081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial.
    El Borolossy R; El-Farsy MS
    Eur J Clin Nutr; 2022 Jun; 76(6):848-854. PubMed ID: 34845313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease.
    Levy DS; Grewal R; Le TH
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F618-F623. PubMed ID: 32830534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
    Grzejszczak P; Kurnatowska I
    Kidney Blood Press Res; 2021; 46(5):523-530. PubMed ID: 34247173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
    Raggi P; Bellasi A; Bushinsky D; Bover J; Rodriguez M; Ketteler M; Sinha S; Salcedo C; Gillotti K; Padgett C; Garg R; Gold A; Perelló J; Chertow GM
    Circulation; 2020 Mar; 141(9):728-739. PubMed ID: 31707860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial.
    Lees JS; Mangion K; Rutherford E; Witham MD; Woodward R; Roditi G; Hopkins T; Brooksbank K; Jardine AG; Mark PB
    Open Heart; 2020 Jul; 7(2):. PubMed ID: 32675297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.